http://rdf.ncbi.nlm.nih.gov/pubchem/reference/35547574

Outgoing Links

Predicate Object
contentType Posted Content
publicationName Research square
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_199db1bef4b0308c0639203aa0befa4f
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_e5a3dcfb8112927712769e828d41101c
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_f0198af1149a3100293da53c9f66101e
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_f21045e3421733f8975c5cd8e41eb86f
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_1b6ce134dfbac54fb2773f9fcd0ec7c9
bibliographicCitation Gerber S, Uccello T, Lesch M, Kintzel S, Gradzewicz L, Lamrous L, Murphy S, Fleming F, Mills B, Murphy J, Hughson A, Garrett-Larsen J, Qiu H, Drage M, Ye J, Gavras N, Keeley D, Love T, Repasky E, Lord E, Linehan D. New insights into the responder/nonresponder divide in rectal cancer: Damage-induced Type I IFNs dictate treatment efficacy and can be targeted to enhance radiotherapy. Res Sq. 2023 Apr 13;(). PMID: 37090639; PMCID: PMC10120761.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d34a163739c58e94160960a43b41dbbe
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bf5eaba436e29852d9d9988b54a4a80b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1eb8c23dddcc76c921846536dbd7b30c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b34e0dcb35a7f827255cd29172506ddb
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_81d0547f5272fc5e6374900a925defd1
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0ee2aa85660b81c65ed89ae00eb31c41
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_38441c7a689c432d2bbb8418d282ddaf
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_94fd218fc98d064343a66159f3d190b0
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d736ef790033f46cbf5f7ca59d9c886a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0bf75183baa7ca10a8448e4a2ac14c64
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_059e977a3f587641c550a369d9bf2417
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a201f64c23367b65db0f0610ad65905c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_51e103d3239fd1e6d5a3e8fb8ca45274
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1840eb1ae4973aa69b04e2f7329d9811
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b6bc2c71c387266984236452526ad123
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3e074af03027890a9efb17a76df9f0b3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2c8a0faff9a95d226d8a49caf84c4f1c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9c53b52029ab4d48c8de07ebda39a7cc
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_179e0ebc9ac8436c24f49c5ca348e08b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_13ab4d8d401340453e6845b9cbede0e8
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b041f4377a4caf84e71c72a76c1585eb
date 2023-04-13^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/37090639
https://pubmed.ncbi.nlm.nih.gov/PMC10120761
https://doi.org/10.21203/rs.3.rs-2767780/v1
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title New insights into the responder/nonresponder divide in rectal cancer: Damage-induced Type I IFNs dictate treatment efficacy and can be targeted to enhance radiotherapy
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_29f84c0d894769b14b36c5f43f54153e
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9060
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7045
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_09306a2f7a5b8562cf4ad73e9a18a9f8
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607

Showing number of triples: 1 to 43 of 43.